Here is a complete, exam-focused explanation of everything across all three images:
Myocardial Infarction (MI) - Complete Notes
Definition
MI = death of cardiac muscle due to prolonged severe ischemia.
- Ischemia lasting 20-30 minutes or longer → irreversible cell injury → MI
- The 2018 joint task force defines it as: "acute myocardial injury detected by abnormal cardiac biomarkers in the setting of evidence of acute myocardial ischemia"
Commonly Involved Vessels
| Vessel | % of MI |
|---|
| Left Anterior Descending (LAD) | 50% - anterior LV wall, anterior 2/3 of septum, apex |
| Right Coronary Artery (RCA) | 30-40% - right ventricle, posterior wall |
| Left Circumflex (LCA/LCX) | 15-20% - lateral LV wall |
Risk Factors
- Atherosclerosis - most common risk factor
- Age: 10% MI under 45 yrs; 45% MI under 65 yrs
- Sex: Males > Females (during reproductive years). Post-menopause, risk equalizes - protective effect of estrogen is lost
- Other: hypertension, diabetes, smoking, dyslipidemia, family history
Etiology
A. Coronary Atherosclerosis (90% of cases)
- Atherosclerotic narrowing of one or more coronary arteries
B. Non-Atherosclerotic (~10% of cases)
- Vasospasm without coronary atherosclerosis
- Emboli from:
- Left atrium (with atrial fibrillation)
- Left-sided mural thrombus
- Vegetations of infective endocarditis
- Intracardiac prosthetic material
- Paradoxical emboli - from right heart/peripheral veins through a patent foramen ovale into coronary arteries
- Other ischemic causes:
- Vasculitis
- Sickle cell disease (hematologic)
- Amyloid deposition in vascular walls
- Vascular dissection
- Lowered systemic BP (shock)
Pathogenesis
Two linked cascades:
Step 1 - Plaque Disruption → Thrombus Formation:
Atheromatous plaque: intraplaque hemorrhage / erosion / ulceration / rupture / fissuring
↓
Exposure of sub-endothelial collagen + necrotic plaque contents
↓
Platelet adherence → activation → release granule contents → aggregate → microthrombi
↓
Vasospasm (from platelet mediators: TXA2, ADP, serotonin)
↓
Activation of coagulation pathway → bulk thrombus → Arterial occlusion
Step 2 - Occlusion → Cell Death:
Severe ischemia
↓
Loss of oxidative phosphorylation → decreased ATP generation
↓
Accumulation of noxious metabolites (lactic acid, Ca²⁺ influx)
↓
Loss of contractility
↓
20-30 mins of ischemia → Irreversible cell injury
↓
Microvascular injury → Myocardial Infarction
Why does subendocardium die first? It is the most distal from epicardial vessels, receives blood last, and is exposed to highest intramural pressures. Ischemia progresses as a wavefront from subendocardium outward toward epicardium.
Types of Infarct (by Wall Thickness Involved)
| Type | Description | ECG | Cause |
|---|
| A. Transmural | Full-thickness; most common; along distribution of one artery | ST elevation (STEMI) | Complete epicardial occlusion |
| B. Subendocardial | Inner 1/3-1/2 of ventricular wall; least common; circumferential | Non-ST elevation (NSTEMI) | Spontaneous or therapeutic lysis before transmural necrosis |
| C. Microscopic | Small vessel occlusion (vasculitis, embolization) | No ECG changes | Small intramyocardial vessel disease |
Morphology - The Key Timeline (MOST EXAM-TESTED)
| Time | Gross Appearance | Microscopy | What's happening |
|---|
| 0-½ hr (reversible) | None | None | ATP loss, mitochondrial swelling only |
| ½-4 hrs | None | Wavy fibers at border | Dead fibers stretch/buckle beside contractile ones |
| 4-12 hrs | Dark mottling | Coagulation necrosis begins; edema + hemorrhage | |
| 12-24 hrs | Dark mottling | Marginal contraction band necrosis; early neutrophilic infiltrate; pyknosis of nuclei | |
| 1-3 days | Mottling with yellow-tan center | Coagulation necrosis with loss of nuclei and striations; massive neutrophilic infiltration | Peak neutrophil response |
| 3-7 days | Hyperemic border; central yellow-tan softening | Dying neutrophils; phagocytes (macrophages) appear | Macrophage phase begins |
| 7-10 days | Depressed red-tan margins | Well-developed phagocytosis; early granulation tissue at margins | Healing starts |
| 10-14 days | Red-gray depressed borders | Granulation tissue with new blood vessels + collagen deposition | Active repair |
| 2-8 weeks | Gray-white scar progressing inward | Increased collagen; decreased cellularity | Scar matures |
| >2 months | Scarring complete | Dense collagenous scar | Healed |
Memory aid for cellular sequence: Wavy → Necrosis → Neutrophils (peak 1-3 days) → Macrophages (3-7 days) → Granulation → Collagen → Scar
Reperfusion
Goal: Restore blood flow to ischemic myocardium to salvage muscle and limit infarct size.
Methods:
- Thrombolysis (tPA)
- Angioplasty + stent placement
- CABG (Coronary Artery Bypass Graft)
Rule: Reversible injury → Reperfusion → muscle saved. After ~20-40 min → irreversible injury.
Reperfusion Injury (the paradox - reperfusion can also cause damage):
- Mitochondrial dysfunction → membrane permeability changes → apoptosis
- Contraction band necrosis - calcium influx causes hypercontraction of sarcomeres → eosinophilic bands (hallmark of reperfused MI on microscopy)
- Free radical damage (ROS: O₂⁻, H₂O₂, •OH)
- "No-reflow" phenomenon - leukocyte aggregation in reperfused microvessels blocks blood flow
- Platelet and complement activation → further microvascular injury
Contraction band necrosis is the microscopic hallmark of reperfused MI. It is NOT seen in non-reperfused MI.
Clinical Features
| Symptom | Notes |
|---|
| Severe chest pain | Crushing, central, radiating to left arm/jaw |
| Dyspnea | From LV failure |
| Rapid weak pulse | Reduced CO |
| Profuse sweating (diaphoresis) | Sympathetic activation |
| Palpitations | Arrhythmias |
| Loss of consciousness | Severe pump failure or arrhythmia |
| Nausea/vomiting | Vagal activation |
| Anxiety, light-headedness, wheezing | |
Investigations
| Investigation | Finding |
|---|
| ECG | ST elevation (STEMI) or ST depression/T-wave changes (NSTEMI) |
| Troponin T & I | Most specific cardiac marker; rises in 3-4 hrs, peaks ~24 hrs, lasts 1-2 weeks |
| CK-MB | Rises 4-8 hrs, peaks 24 hrs, returns to normal in 48-72 hrs |
| Myoglobin | Earliest marker (rises 1-2 hrs), but not cardiac-specific |
| LDH | Rises late (24-48 hrs), stays elevated for 10-14 days |
| SGOT/AST | Non-specific, rises in 8-12 hrs |
| Blood tests | Raised TLC, ESR, CRP (markers of inflammation) |
| Chest X-ray | Pulmonary congestion, cardiomegaly |
| Echocardiography | Wall motion abnormalities, EF assessment |
Complications
Severity depends on: infarct size + location + thickness (transmural vs subendocardial)
| Category | Complication | Notes |
|---|
| Contractile dysfunction | LV failure | Most common complication |
| Cardiogenic shock | In 10-15% of patients; pump failure |
| RV failure, pulmonary congestion | |
| Arrhythmias | Sinus bradycardia, heart block, asystole | From SA/AV node ischemia (RCA territory) |
| Tachycardia, ventricular fibrillation | Most common cause of sudden death post-MI (80-90% of early deaths) |
| Myocardial rupture | Hemopericardium + cardiac tamponade | Occurs 3-7 days (when myocardium is soft); most lethal |
| VSD (interventricular septal rupture) | Left-to-right shunt |
| Papillary muscle rupture | → Acute mitral regurgitation |
| Pericarditis | Fibrinous/fibrohemorrhagic pericarditis | Develops day 2-3 after transmural MI |
| Dressler syndrome | Autoimmune pericarditis weeks later |
| Structural | Chamber dilation, infarct expansion | Early remodeling |
| Ventricular aneurysm | Thinned wall bulges - mural thrombi form here |
| Mural embolism | From mural thrombus in dilated/aneurysmal LV |
| Papillary muscle dysfunction | → Mitral regurgitation (without rupture) |
| Progressive late heart failure | Long-term LV remodeling |
Quick Summary Diagram
PLAQUE RUPTURE → THROMBUS → OCCLUSION
↓
0-½ hr: Reversible (wavy fibers)
½-4 hr: Coagulation necrosis begins
1-3 days: Neutrophil peak
3-7 days: Macrophages, softening
7-14 days: Granulation tissue
2-8 wks: Collagen scar
>2 months: Dense fibrotic scar
REPERFUSION → contraction band necrosis
COMPLICATIONS:
Early → Arrhythmias (VF), rupture (3-7d)
Mid → Pericarditis (day 2-3)
Late → Aneurysm, HF, Dressler syndrome
- Robbins & Kumar Basic Pathology, p. 353-360